Comprehensive Study Guide on Solid Dosage Forms and Pharmaceutical Manufacturing
- Solid dosage forms are formulated to contain a precise and exact amount of the drug itself. There is no such concept as an approximate amount of dosing for these preparations.
- Precision in dosing is critical for patient safety and therapeutic efficacy.
- Tablets often feature physical markers for identification and dosing accuracy:
- Scoring: A mark in the middle of the tablet allowing it to be split.
- Imprints: Identification numbers or letters indicating the dosage or manufacturer.
- Tablets are generally designed to be easy to swallow, though some formulations may be larger or specifically designed to resist compression until reached by the target environment.
- The formulation process must ensure that the bioavailability of the drug is not negatively altered.
- An ideal tablet must be free of defects, including:
- Chips
- Cracks
- Serration
- Contamination
- Friability: This is defined as a tablet's tendency to crumble or break during handling or transportation.
- Friability Test: This test measures a tablet's resistance to mechanical stress and production processes without experiencing significant mass loss.
- Drug release must occur in a predictable and usable manner to ensure effective absorption and onset of action.
- The typical peak of absorption should occur within approximately 30minutes for standard immediate-release formulations. Following the peak, the drug enters the elimination phase.
Pharmaceutical Ingredients: Actives and Excipients
- Active Ingredients: These are the medicinal components responsible for the therapeutic effect.
- Excipients: These are non-active ingredients that serve specific functions in the formulation. Common excipients include:
- Diluents: Materials used to add bulk to a tablet (e.g., Lactose anhydrous, Calcium phosphate, Mannitol, Cellulose family).
- Disintegrants: Starch is a common example, used to aid the tablet in breaking apart in the gastrointestinal tract.
- Lubricants: Added during granulation or before compression to prevent the material from sticking to the machinery.
Tablet Manufacturing Methodologies
Direct Compression
- This process involves mixing dry active ingredients and excipients together to create a blend used for immediate compression.
- It does not involve the creation of granules.
- The workflow involves milling for size reduction, followed by mixing, and finally direct compression where the powder is pressed into a mold and ejected.
- This is a very fast manufacturing process.
Dry Granulation (The Slugging Method)
- In this method, a "slug" is formed and then ground to a uniform size before being compressed into finished tablets.
- Equipment used often includes a V blender, which can be extremely large (spanning the height of two floors).
- A screen is utilized during the process to ensure the granules achieve the correct size.
- After the initial slugging and screening, the material is blended again, potentially with a lubricant, before final compression.
Wet Granulation
- This method involves the use of liquids to assist in the granulation process.
- It is more time-consuming and involves more manipulation than dry methods.
- It is not suitable for drugs that are:
- Thermolabile (Thermal): Sensitive to heat, as the granules must be dried in an oven.
- Hydrolyzable: Sensitive to water or moisture, which is introduced during the wet mixing phase.
- Process steps include:
- Mixing the drug and diluent.
- Adding a liquid solution to create a mass.
- Passing the mass through a screen to size the granules.
- Drying the granules in an oven.
- Re-screening to ensure uniformity.
- Final compression.
- Granulation improves the compressibility of tablets and ensures a more even distribution of the active ingredient.
Tablet Compression Equipment and Mechanical Problems
- Single Punch Tablet Press: A laboratory-scale machine consisting of two main parts:
- Bottom Piece: Contains a cavity or mold.
- Top Piece (Small Rod): Punches down into the mold to compress the drug/excipient mixture into a tablet.
- Commercial tablet presses may have limited flexibility regarding size and shape compared to compounding facilities, but they can produce thousands of tablets in a short timeframe.
- Tablet Processing Problems:
- Capping/Delamination: Separation of the tablet, often caused by air entrapment during compression.
- Lamination: The separation of the tablet into two or more distinct layers.
- Picking: The removal of surface material from the tablet during manufacture.
Modified Release and Specialized Coating
- Enteric Coating: This coating allows a tablet to resist the acidic pH of the stomach and instead release the drug in the intestine. Cellulose-based materials are common for this purpose.
- Multiple Layer Tablets: Formed through multiple compression steps, these tablets can combine several drugs or different release profiles within a single unit.
- Controlled vs. Sustained Release:
- Controlled Release: The drug is released at a constant, predetermined rate over a set period.
- Sustained Release: These provide an initial "burst" of release followed by a slow, gradual release over time.
Pharmacokinetic Analysis of Release Profiles
- Key Parameters on a Concentration-Time Graph:
- Y-axis: Blood sample concentration (C\text{max}).
- X-axis: Time (T\text{max}).
- Maximum Safe Level: The threshold above which the drug concentration becomes unstable or toxic.
- Minimum Effective Concentration (MEC): The line below which the drug is sub-therapeutic and provides no effect.
- Onset of Action: The time it takes for the drug to reach the MEC. Ordinary tablets have a fast onset (<1hour). Sustained-release tablets have a delayed onset.
- Duration of Action: The total time the drug concentration remains above the MEC. Sustained-release forms provide a significantly longer duration of action compared to ordinary tablets.
Drug Degradation and Stability
- Primary Chemical Degradation Processes:
- Hydrolysis: The most common process responsible for drug degradation.
- Oxidation.
- Photolysis.
- Trace Metals.
- Environmental Factors:
- UV Light: Identified as the most destructive/degradable visible wave for drug stability.
- Accelerated Stability Testing: This involves placing a drug in an environment where conditions (heat, humidity) are exaggerated to accelerate degradation. This data is used to extrapolate the drug's shelf life and stability profile.
Comminution: Particle Size Reduction
- Comminution is the process of reducing the particle size of a solid material.
- There are three primary processes of comminition:
- Trituration: Grinding a powder in a mortar and pestle.
- Levigation: Reducing particle size with the help of a small amount of liquid (a levigating agent).
- Milling: Mechanical size reduction used in large-scale production.
Questions & Discussion
- Question: Which environmental factor is most responsible for drug degradation?
- Response: UV light is the most destructive.
- Question: Which chemical process is most frequently responsible for drug degradation?
- Response: Hydrolysis.
- Question: What is the purpose of accelerated stability testing?
- Response: We are accelerating the conditions of the environment to accelerate drug degradation in order to extrapolate the stability problems of the drug.
- Question: What are the three processes of comminition?
- Response: Trituration, levigation, and milling.